← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$56K

Shares

2,800

Price

$20

Filed

Sep 25

Insider

Name

Kintz Samuel

Title

PRESIDENT AND CEO

CIK

0001967168

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-23

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

919,092

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. | The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.

Filing Info

Accession No.

0001967168-25-000005

Form Type

4

Issuer CIK

0001672619

Kintz Samuel's History

Date Ticker Type Value
2025-11-17 ELVN $273K
2025-10-17 ELVN $267K
2025-09-26 ELVN $74K
2025-09-23 ELVN $56K
2025-09-19 ELVN $20K
2025-09-17 ELVN $95K
2025-08-20 ELVN $30K
2025-08-19 ELVN $12K
2025-08-18 ELVN $208K
2025-07-17 ELVN $90K

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.2M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12